Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitors

Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitors

US Patent 12214036 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent2024
Binding molecules specific for CD73 and uses thereof2022
Low dose combination therapy for treatment of myeloproliferative neoplasms2022
Low dose combination therapy for treatment of myeloproliferative neoplasms2020
Binding molecules specific for CD73 and uses thereof2020
Binding molecules specific for CD73 and uses thereof2019
Binding molecules specific for CD73 and uses thereof2018
Polymer micelles containing anthracylines for the treatment of cancer2013
Polymer micelles containing anthracylines for the treatment of cancer2013
Methods and compositions for enhancing the immunostimulatory effect of interleuk2002